News

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...
In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...
LinkGevity is among a cluster of biotech firms in Cambridge working on potential longevity treatments. They include clock.bio ...
The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for ...
A WOMAN has revealed that she has shed 7kg without the help of Mounjaro. Since becoming available on the NHS earlier this ...
People on weight-loss drugs often lose muscle mass while they lose weight, but new scientific findings suggest boosting your ...
The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?
People are injecting peptides to build muscle, trim fat, and reduce inflammation. Does it work?